MIDAS Syndrome (Microphthalmia with Linear Skin Defects)

Standard

MIDAS Syndrome (Microphthalmia with Linear Skin Defects). / Hagel, Christian; Panteliadis, Christos.

Neurocutaneous Disorders: A Clinical, Diagnostic and Therapeutic Approach . Hrsg. / Christos Panteliadis; Ramsis Benjamin; Christian Hagel. 3. Aufl. Zürich : Springer International Publishing, 2022. S. 227-230.

Publikationen: SCORING: Beitrag in Buch/SammelwerkKapitelForschung

Harvard

Hagel, C & Panteliadis, C 2022, MIDAS Syndrome (Microphthalmia with Linear Skin Defects). in C Panteliadis, R Benjamin & C Hagel (Hrsg.), Neurocutaneous Disorders: A Clinical, Diagnostic and Therapeutic Approach . 3 Aufl., Springer International Publishing, Zürich, S. 227-230.

APA

Hagel, C., & Panteliadis, C. (2022). MIDAS Syndrome (Microphthalmia with Linear Skin Defects). in C. Panteliadis, R. Benjamin, & C. Hagel (Hrsg.), Neurocutaneous Disorders: A Clinical, Diagnostic and Therapeutic Approach (3 Aufl., S. 227-230). Springer International Publishing.

Vancouver

Hagel C, Panteliadis C. MIDAS Syndrome (Microphthalmia with Linear Skin Defects). in Panteliadis C, Benjamin R, Hagel C, Hrsg., Neurocutaneous Disorders: A Clinical, Diagnostic and Therapeutic Approach . 3 Aufl. Zürich: Springer International Publishing. 2022. S. 227-230

Bibtex

@inbook{034b62b26c2243639118dbdbb311dab8,
title = "MIDAS Syndrome (Microphthalmia with Linear Skin Defects)",
abstract = "Microphthalmia, dermal aplasia, and sclerocornea (acronym MIDAS) or microphthalmia with linear skin defects (MLS; OMIM 309801) was first described in 1988 in three patients with XY translocations and alterations at Xp22.3. The disorder is X-linked and lethal in males with a hemizygous state (XY). It is caused by mutations in genes coding for enzymes of the mitochondrial respiratory chain. The most consistent clinical features of MIDAS are microphthalmia and/or anophthalmia, sclerocornea, and linear skin defects with dermal aplasia limited to face and neck. Additional findings may include agenesis of corpus callosum, chorioretinal abnormalities, hydrocephalus, anal atresia with ectopic anus, seizures, intellectual deficit, and nail dystrophy. At present, about 50 well-documented cases have been registered worldwide. The etiology, clinical features, diagnosis, and recommendations are reviewed in this chapter.",
author = "Christian Hagel and Christos Panteliadis",
year = "2022",
month = feb,
day = "4",
language = "English",
isbn = "978-3-030-87892-4",
pages = "227--230",
editor = "Christos Panteliadis and Ramsis Benjamin and Christian Hagel",
booktitle = "Neurocutaneous Disorders",
publisher = "Springer International Publishing",
address = "Switzerland",
edition = "3",

}

RIS

TY - CHAP

T1 - MIDAS Syndrome (Microphthalmia with Linear Skin Defects)

AU - Hagel, Christian

AU - Panteliadis, Christos

PY - 2022/2/4

Y1 - 2022/2/4

N2 - Microphthalmia, dermal aplasia, and sclerocornea (acronym MIDAS) or microphthalmia with linear skin defects (MLS; OMIM 309801) was first described in 1988 in three patients with XY translocations and alterations at Xp22.3. The disorder is X-linked and lethal in males with a hemizygous state (XY). It is caused by mutations in genes coding for enzymes of the mitochondrial respiratory chain. The most consistent clinical features of MIDAS are microphthalmia and/or anophthalmia, sclerocornea, and linear skin defects with dermal aplasia limited to face and neck. Additional findings may include agenesis of corpus callosum, chorioretinal abnormalities, hydrocephalus, anal atresia with ectopic anus, seizures, intellectual deficit, and nail dystrophy. At present, about 50 well-documented cases have been registered worldwide. The etiology, clinical features, diagnosis, and recommendations are reviewed in this chapter.

AB - Microphthalmia, dermal aplasia, and sclerocornea (acronym MIDAS) or microphthalmia with linear skin defects (MLS; OMIM 309801) was first described in 1988 in three patients with XY translocations and alterations at Xp22.3. The disorder is X-linked and lethal in males with a hemizygous state (XY). It is caused by mutations in genes coding for enzymes of the mitochondrial respiratory chain. The most consistent clinical features of MIDAS are microphthalmia and/or anophthalmia, sclerocornea, and linear skin defects with dermal aplasia limited to face and neck. Additional findings may include agenesis of corpus callosum, chorioretinal abnormalities, hydrocephalus, anal atresia with ectopic anus, seizures, intellectual deficit, and nail dystrophy. At present, about 50 well-documented cases have been registered worldwide. The etiology, clinical features, diagnosis, and recommendations are reviewed in this chapter.

M3 - Chapter

SN - 978-3-030-87892-4

SP - 227

EP - 230

BT - Neurocutaneous Disorders

A2 - Panteliadis, Christos

A2 - Benjamin, Ramsis

A2 - Hagel, Christian

PB - Springer International Publishing

CY - Zürich

ER -